Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Amphastar Pharmaceuticals Inc AMPH

Healthcare
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AMPH)

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

Accesswire June 4, 2024

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Accesswire June 3, 2024

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Accesswire May 22, 2024

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

Accesswire May 9, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Accesswire May 8, 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Accesswire April 30, 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Accesswire April 1, 2024

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

Accesswire March 6, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

Accesswire February 28, 2024
View More News ››

Opinion & Analysis (NDAQ:AMPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AMPH)

AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITI

$AMPH Excited to share an article about Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company focusing...
AviseAnalytics - March 13, 2023
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canada-based mineral exploration company. The Company is engaged in the identification, acquisition, ...
View More »